P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date
Decision
P/0169/2024: EMA decision of 6 May 2024 on the agreement of a paediatric investigation plan and on the granting of a waiver for nivolumab / relatlimab (Opdualag), (EMEA-002727-PIP03-23)